NGL FINE CHEM LIMITED
NGLFINE · General/Diversified · NSE
₹2,236
Current Market Price
Fair Value (DCF)
₹601
Margin of Safety
-73.1%
Updated just now
YieldIQ Score
22/100
Piotroski F-Score
3/9
Economic Moat
None
Confidence
21%
ROE
—
Debt/Equity
0.29
WACC
11.1%
Market Cap
₹1,381 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
9.6%
Return on capital employed
EV / EBITDA
26.7×
Enterprise multiple
Debt / EBITDA
1.5×
Leverage vs earnings
Interest Coverage
12.9×
EBIT covers interest
Current Ratio
1.98×
Short-term liquidity
Asset Turnover
0.84×
Revenue per ₹ of assets
Revenue CAGR (3Y)
5.1%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹2,235.9
Bear case
₹385.2
MoS -480.5%
Base case
₹601.08
MoS -272.0%
Bull case
₹866.78
MoS -158.0%
Ratio Trends
NGLFINE · last 4 annual periods
ROE
7.5%
ROCE
11.8%
Operating Margin
—
Debt / Equity
0.27×
PE
36.2×
EV / EBITDA
19.1×
Historical Financials
NGLFINE · Annual, last 4 years· amounts in ₹Cr unless noted
| Metric | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | ₹313 Cr | ₹274 Cr | ₹334 Cr | ₹363 Cr | +5.1% |
| EBITDA | ₹78.5 Cr | ₹39.9 Cr | ₹67.4 Cr | ₹42.5 Cr | -18.5% |
| EBIT | — | ₹12.4 Cr | ₹16.6 Cr | — | +10.2% |
| PAT | ₹49.9 Cr | ₹20.5 Cr | ₹41.3 Cr | ₹21.1 Cr | -24.9% |
| EPS (diluted) | — | ₹15.09 | ₹19.95 | — | +9.8% |
| CFO | ₹13.8 Cr | ₹35.3 Cr | ₹20.5 Cr | ₹35.8 Cr | +37.4% |
| CapEx | ₹-56.4 Cr | — | — | ₹-131 Cr | — |
| FCF | ₹-42.6 Cr | — | — | ₹-94.9 Cr | — |
| Total Assets | ₹277 Cr | ₹287 Cr | ₹356 Cr | ₹433 Cr | +16.1% |
| Total Debt | ₹30.0 Cr | ₹28.4 Cr | ₹31.7 Cr | ₹77.1 Cr | +37.0% |
| Shareholders' Equity | ₹203 Cr | ₹223 Cr | ₹263 Cr | ₹282 Cr | +11.6% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
NGLFINE vs 4 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| TTKHLTCARE TTKHLTCARE | — | — | Pending | 7.7% | — |
| SAIPARENT SAIPARENT | — | — | Pending | 15.9% | — |
| SMSPHARMA SMSPHARMA | — | — | Pending | 10.8% | — |
| SENORES SENORES | — | — | Pending | 7.2% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for NGLFINE in the last 10 years.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of NGLFINE →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for NGLFINE →
Compare
Head-to-head with peers
Compare NGLFINE side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse NGLFINENow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.